Reaktionsgleichung
Cl[C:2]1[N:7]=[C:6]([C:8]([F:11])([F:10])[F:9])[N:5]=[C:4]([NH:12][CH:13]2[CH2:18][CH2:17][N:16]([C:19]([O:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[O:20])[CH2:15][CH2:14]2)[CH:3]=1.C([Sn](CCCC)(CCCC)/[CH:31]=[CH:32]\[O:33][CH2:34][CH3:35])CCC>C1(C)C=CC=CC=1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:34]([O:33]/[CH:32]=[CH:31]\[C:2]1[N:7]=[C:6]([C:8]([F:11])([F:10])[F:9])[N:5]=[C:4]([NH:12][CH:13]2[CH2:18][CH2:17][N:16]([C:19]([O:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[O:20])[CH2:15][CH2:14]2)[CH:3]=1)[CH3:35]Komponenten
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Reaktionsbedingungen
- Temperatur
- 110 °C
Versuchsvorschrift
A mixture of tert-butyl 4-{[6-chloro-2-(trifluoromethyl)pyrimidin-4-yl]amino}piperidine-1-carboxylate (1.0 g, 2.6 mmol, from Step 1), tributyl[(Z)-2-ethoxyvinyl]stannane (0.96 mL, 2.9 mmol, Synthonix Corp.) and tetrakis(triphenylphosphine)palladium(0) (0.15 g, 0.13 mmol, Strem) in toluene (3.0 mL) was degassed and then heated to 110° C. for 3 hours, then lowered to 90° C. overnight. The mixture was concentrated and flash chromatographed on a 120 g silica gel cartridge, eluting with a gradient from 0-20% EtOAc in hexanes to afford product as a white solid (0.8 g, 73%). 1H NMR (400 MHz, CDCl3) δ 7.08 (s, 1H), 6.58 (d, J=7.1 Hz, 1H), 5.40 (d, J=7.1 Hz, 1H), 4.98 (br s, 1H), 4.18-4.00 (m, 4H), 3.82 (br s, 1H), 2.94 (t, J=11.7 Hz, 2H), 2.12-1.95 (m, 2H), 1.52-1.31 (m, 14H). 19F NMR (376 MHz, CDCl3) δ −71.77 (s). LCMS (M+H): 417.2.
Aufarbeitung
- customwas degassed
- concentrationThe mixture was concentrated
- customflash chromatographed on a 120 g silica gel cartridge
- washeluting with a gradient from 0-20% EtOAc in hexanes
Quellen und Nachweise
- ORD-Eintrag
- ord-a19bb37cdef4489593fa7ef193a51f14
- Quelldatensatz
- uspto-grants-2015_11
- Patentnummer
- US09193733B2
Verknüpfte Notizen
Wird geladen…